$NYC
American Strategic Investment Co. Stock $nyc

$nyc Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000159552723000019 Filed on May 12, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$15.78M	$15.53M
YoY Change	-2.77%	-0.72%
Cost Of Revenue	$10.34M	$10.31M
YoY Change	2.84%	-1.86%
Gross Profit	$5.441M	$5.229M
YoY Change	-11.9%	1.61%
Gross Profit Margin	34.48%	33.66%
Selling, General & Admin	$4.743M	$5.381M
YoY Change	-16.89%	19.1%
% of Gross Profit	87.17%	102.91%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$6.749M	$6.952M
YoY Change	-4.15%	-0.42%
% of Gross Profit	124.04%	132.95%
Operating Expenses	$11.49M	$12.33M
YoY Change	-9.85%	7.25%
Operating Profit	-$6.202M	-$7.104M
YoY Change	-5.63%	11.82%
Interest Expense	$4.707M	$4.663M
YoY Change	0.09%	-1.1%
% of Operating Profit
Other Income/Expense, Net	-$4.697M	-$4.654M
YoY Change	-0.09%	-2.06%
Pretax Income	-$10.90M	-$11.76M
YoY Change	-3.32%	5.88%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$10.90M	-$11.76M
YoY Change	-3.32%	5.88%
Net Earnings / Revenue	-69.06%	-75.69%
Basic Earnings Per Share	-$4.77	-$5.77
Diluted Earnings Per Share	-$4.77	-$5.77
COMMON SHARES
Basic Shares Outstanding	2.303M shares	2.304M shares
Diluted Shares Outstanding	2.287M shares	2.039M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.052M	$8.753M
YoY Change	-12.91%	-15.36%
Cash & Equivalents	$7.052M	$8.753M
Short-Term Investments
Other Short-Term Assets	$5.540M	$6.082M
YoY Change	-39.61%	6.14%
Inventory
Prepaid Expenses
Receivables	$29.20M	$29.32M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$41.79M	$44.16M
YoY Change	-7.83%	2.18%
LONG-TERM ASSETS
Property, Plant & Equipment	$716.8M	$722.7M
YoY Change	-2.86%	-2.88%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$15.69M	$18.21M
YoY Change	-28.25%	-19.8%
Total Long-Term Assets	$733.7M	$742.1M
YoY Change	-3.54%	-3.24%
TOTAL ASSETS
Total Short-Term Assets	$41.79M	$44.16M
Total Long-Term Assets	$733.7M	$742.1M
Total Assets	$775.5M	$786.3M
YoY Change	-3.78%	-2.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.05M	$13.11M
YoY Change	-21.67%	29.31%
Accrued Expenses	$54.69M	$54.70M
YoY Change	-0.1%	-0.1%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$66.73M	$67.82M
YoY Change	-7.9%	4.49%
LONG-TERM LIABILITIES
Long-Term Debt	$394.9M	$394.5M
YoY Change	0.39%	0.39%
Other Long-Term Liabilities	$6.330M	$7.767M
YoY Change	-13.16%	-10.55%
Total Long-Term Liabilities	$401.3M	$402.3M
YoY Change	0.15%	0.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$66.73M	$67.82M
Total Long-Term Liabilities	$401.3M	$402.3M
Total Liabilities	$468.0M	$470.1M
YoY Change	-0.6%	0.76%
SHAREHOLDERS EQUITY
Retained Earnings	-$422.0M	-$411.1M
YoY Change	12.29%	13.2%
Common Stock	$23.00K	$23.00K
YoY Change	-83.09%	-82.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$282.8M	$293.6M
YoY Change
Total Liabilities & Shareholders Equity	$775.5M	$786.3M
YoY Change	-3.78%	-2.95%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$10.90M	-$11.76M
YoY Change	-3.32%	5.88%
Depreciation, Depletion And Amortization	$6.749M	$6.952M
YoY Change	-4.15%	-0.42%
Cash From Operating Activities	-$3.435M	-$742.0K
YoY Change	678.91%	-134.07%
INVESTING ACTIVITIES
Capital Expenditures	$493.0K	$2.308M
YoY Change	-150.93%	-668.47%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$493.0K	-$2.308M
YoY Change	-49.07%	468.47%
FINANCING ACTIVITIES
Cash Dividend Paid		$0.00
YoY Change		-100.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-10.00K	$4.035M
YoY Change	-99.28%	-158.74%
NET CHANGE
Cash From Operating Activities	-3.435M	-$742.0K
Cash From Investing Activities	-493.0K	-$2.308M
Cash From Financing Activities	-10.00K	$4.035M
Net Change In Cash	-3.938M	$985.0K
YoY Change	41.15%	-119.33%
FREE CASH FLOW
Cash From Operating Activities	-$3.435M	-$742.0K
Capital Expenditures	$493.0K	$2.308M
Free Cash Flow	-$3.928M	-$3.050M
YoY Change	-845.35%	-218.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001595527
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	nycr	Advisory Agreement Board Of Directors Approval Percentage AdvisoryAgreementBoardOfDirectorsApprovalPercentage	0.66
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-39448
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	American Strategic Investment Co.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-4380248
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	650 Fifth Ave.,
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	30th Floor
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10019
CY2023Q1	dei	City Area Code CityAreaCode	212
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	415-6500
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2302951	shares
CY2023Q1	us-gaap	Land Land	192600000	usd
CY2022Q4	us-gaap	Land Land	192600000	usd
CY2023Q1	nycr	Buildings Fixturesand Improvements BuildingsFixturesandImprovements	578127000	usd
CY2022Q4	nycr	Buildings Fixturesand Improvements BuildingsFixturesandImprovements	576686000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	71848000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	71848000	usd
CY2023Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	842575000	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	841134000	usd
CY2023Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	174786000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	167978000	usd
CY2023Q1	us-gaap	Assets Assets	786283000	usd
CY2022Q4	us-gaap	Assets Assets	790455000	usd
CY2023Q1	nycr	Secured Debt Netof Deferred Financing Costs SecuredDebtNetofDeferredFinancingCosts	394545000	usd
CY2023Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	667789000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	673156000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8753000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9215000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	8349000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	6902000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	54901000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	54954000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	6082000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	5624000	usd
CY2023Q1	us-gaap	Derivative Assets DerivativeAssets	1230000	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	1607000	usd
CY2023Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	29323000	usd
CY2022Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	29116000	usd
CY2023Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	9856000	usd
CY2022Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	9881000	usd
CY2022Q4	nycr	Secured Debt Netof Deferred Financing Costs SecuredDebtNetofDeferredFinancingCosts	394159000	usd
CY2023Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	437000	usd
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	118000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	13113000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	12787000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	54702000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	54716000	usd
CY2023Q1	us-gaap	Below Market Lease Net BelowMarketLeaseNet	2750000	usd
CY2022Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	3006000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5017000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4211000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	470127000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	468879000	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2303895	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2303895	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1886298	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1886298	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	23000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	19000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	703385000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	698761000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1255000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1637000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-411113000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-399355000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	293550000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	301062000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	22606000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	20514000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	316156000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	321576000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	786283000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	790455000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	15534000	usd
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	15646000	usd
CY2023Q1	nycr	Asset And Property Management Fees To Related Parties AssetAndPropertyManagementFeesToRelatedParties	1884000	usd
CY2022Q1	nycr	Asset And Property Management Fees To Related Parties AssetAndPropertyManagementFeesToRelatedParties	1922000	usd
CY2023Q1	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	8421000	usd
CY2022Q1	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	8597000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2200000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2120000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3181000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2986000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6952000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6981000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	22638000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	22606000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7104000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6960000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	4663000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	4715000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-37000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4654000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4752000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11758000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11712000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-382000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	1750000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-382000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1750000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-12140000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-9962000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2038880	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2038880	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1662456	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1662456	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.77
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.77
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.07
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.07
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	321576000	usd
CY2023Q1	nycr	Stock Issued During Period Value Warrants And Rights StockIssuedDuringPeriodValueWarrantsAndRights	4059000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	485000	usd
CY2023Q1	nycr	Stock Redeemed During Period Value StockRedeemedDuringPeriodValue	24000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2200000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-11758000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-382000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	316156000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	351136000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1008000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2120000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	59000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.60
CY2022Q1	us-gaap	Dividends Dividends	1329000	usd
CY2022Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	40000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-11712000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1750000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	342992000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-11758000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-11712000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6952000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6981000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	386000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	385000	usd
CY2023Q1	nycr	Accretionand Amortizationof Belowand Above Market Lease Intangible Assetsand Liabilities AccretionandAmortizationofBelowandAboveMarketLeaseIntangibleAssetsandLiabilities	-36000	usd
CY2022Q1	nycr	Accretionand Amortizationof Belowand Above Market Lease Intangible Assetsand Liabilities AccretionandAmortizationofBelowandAboveMarketLeaseIntangibleAssetsandLiabilities	51000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2200000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2120000	usd
CY2023Q1	nycr	Management Fees Reinvested ManagementFeesReinvested	485000	usd
CY2022Q1	nycr	Management Fees Reinvested ManagementFeesReinvested	1008000	usd
CY2023Q1	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	204000	usd
CY2022Q1	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	1303000	usd
CY2023Q1	nycr	Increase Decreasein Straight Line Rent Payable IncreaseDecreaseinStraightLineRentPayable	27000	usd
CY2022Q1	nycr	Increase Decreasein Straight Line Rent Payable IncreaseDecreaseinStraightLineRentPayable	27000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	865000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3067000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1193000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1991000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	806000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-335000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-742000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2178000	usd
CY2023Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	2308000	usd
CY2022Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	406000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2308000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-406000	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	5500000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	4059000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	0	usd
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	1329000	usd
CY2023Q1	nycr	Payment For Redemption Of Stock PaymentForRedemptionOfStock	24000	usd
CY2022Q1	nycr	Payment For Redemption Of Stock PaymentForRedemptionOfStock	0	usd
CY2023Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	usd
CY2022Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	40000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4035000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6869000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	985000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5097000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16117000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28428000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17102000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23331000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8753000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10342000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	8349000	usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	12989000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17102000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23331000	usd
CY2023Q1	nycr	Stock Issued For Services StockIssuedForServices	0	usd
CY2022Q1	nycr	Stock Issued For Services StockIssuedForServices	59000	usd
CY2023Q1	nycr	Increase Decrease In Accrued Capital Expenditures IncreaseDecreaseInAccruedCapitalExpenditures	-867000	usd
CY2022Q1	nycr	Increase Decrease In Accrued Capital Expenditures IncreaseDecreaseInAccruedCapitalExpenditures	685000	usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1	485000	usd
CY2022Q1	us-gaap	Stock Issued1 StockIssued1	1008000	usd
CY2023Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	8	property
CY2023Q1	us-gaap	Net Rentable Area NetRentableArea	1200000	sqft
CY2023Q1	nycr	Aggregate Purchase Priceof Real Estate AggregatePurchasePriceofRealEstate	790700000	usd
CY2023Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.125
CY2023Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	5000000	usd
CY2022Q1	us-gaap	Assets Assets	810182000	usd
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	10748000	usd
CY2022Q1	us-gaap	Liabilities Liabilities	467190000	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-363790000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	328753000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	342992000	usd
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	15646000	usd
CY2022Q1	nycr	Asset And Property Management Fees To Related Parties AssetAndPropertyManagementFeesToRelatedParties	1922000	usd
CY2022Q1	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	8597000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2120000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2986000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6981000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	22606000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6960000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	4715000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-37000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4752000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11712000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	1750000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	1750000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9962000	usd
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1662456	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1662456	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.07
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.07
CY2021Q4	nycr	Distributions In Excess Of Accumulated Earnings DistributionsInExcessOfAccumulatedEarnings	-350709000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	351136000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-11712000	usd
CY2022Q1	nycr	Distributions In Excess Of Accumulated Earnings DistributionsInExcessOfAccumulatedEarnings	-363790000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	342992000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11712000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1991000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	99000000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Management makes significant estimates regarding revenue recognition, purchase price allocations to record investments in real estate, and fair value measurements, as applicable.</span></div>
CY2023Q1	nycr	Lessor Operating Lease Weighted Average Remaining Lease Term LessorOperatingLeaseWeightedAverageRemainingLeaseTerm	P7Y
CY2023Q1	us-gaap	Debt Instrument Collateral Amount DebtInstrumentCollateralAmount	826900000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	49500000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	140000000	usd
CY2023Q1	nycr	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	111000000	usd
CY2023Q1	us-gaap	Secured Debt SecuredDebt	399500000	usd
CY2023Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	24308	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	1230000	usd
CY2023Q1	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2023Q1	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	0	usd
CY2023Q1	us-gaap	Derivative Assets DerivativeAssets	1230000	usd
CY2023Q1	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	usd
CY2023Q1	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	1230000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	1607000	usd
CY2022Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2022Q4	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	0	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	1607000	usd
CY2022Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	usd
CY2022Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	1607000	usd
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2300000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1900000	shares
CY2022Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.60
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P43Y9M18D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.086
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	54900000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	54700000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1200000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	1200000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1200000	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	1200000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	3560000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4746000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4746000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4746000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4746000	usd
CY2023Q1	nycr	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	193008000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	215552000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	160850000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	54702000	usd
CY2023Q1	nycr	Advisory Agreement Renewal Term AdvisoryAgreementRenewalTerm	P5Y
CY2018Q4	nycr	Period Prior To Expiration Date Needed To Terminate Agreement PeriodPriorToExpirationDateNeededToTerminateAgreement	P180D
CY2023Q1	nycr	Related Party Transaction Asset Management Fee Percentageof Benchmark RelatedPartyTransactionAssetManagementFeePercentageofBenchmark	0.0125
CY2023Q1	us-gaap	Management Fee Expense ManagementFeeExpense	1500000	usd
CY2022Q1	us-gaap	Management Fee Expense ManagementFeeExpense	1500000	usd
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	129671	shares
CY2023Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	3245000	usd
CY2022Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	3406000	usd
CY2023Q1	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	-437000	usd
CY2022Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	-118000	usd
CY2020Q3	nycr	Equity Based Compensation Consecutive Trading Days EquityBasedCompensationConsecutiveTradingDays	30	trading_day
CY2020Q3	nycr	Equity Based Compensation Consecutive Trading Days EquityBasedCompensationConsecutiveTradingDays	10	trading_day
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2100000	usd
CY2023Q1	nycr	Distributions On The Ltip Unit DistributionsOnTheLTIPUnit	0.10
CY2023Q1	nycr	Distribution On The Earned Ltip Unit DistributionOnTheEarnedLTIPUnit	0.90
CY2023Q1	nycr	Share Based Compensation Arrangement By Share Based Payment Award Performance Period ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod	P3Y
CY2023Q1	nycr	Share Based Compensation Arrangement By Share Based Payment Award Performance Period ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod	P3Y
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	1
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11758000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11712000	usd
CY2023Q1	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2022Q1	us-gaap	Dilutive Securities DilutiveSecurities	-40000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-11758000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-11752000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2038880	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2038880	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1662456	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1662456	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.77
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.77
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.07
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.07
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	521709	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	504752	shares

Files In Submission

Name	View Source	Status
0001595527-23-000019-index-headers.html	Edgar Link	pending
0001595527-23-000019-index.html	Edgar Link	pending
0001595527-23-000019.txt	Edgar Link	pending
0001595527-23-000019-xbrl.zip	Edgar Link	pending
ex311asic3312023.htm	Edgar Link	pending
ex312asic3312023.htm	Edgar Link	pending
ex32asic33123.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nycr-20230331.htm	Edgar Link	pending
nycr-20230331.xsd	Edgar Link	pending
nycr-20230331_g1.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
nycr-20230331_def.xml	Edgar Link	unprocessable
nycr-20230331_cal.xml	Edgar Link	unprocessable
nycr-20230331_lab.xml	Edgar Link	unprocessable
nycr-20230331_pre.xml	Edgar Link	unprocessable
nycr-20230331_htm.xml	Edgar Link	completed
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NYC
American Strategic Investment Co. Stock $nyc

2023 Q2 Form 10-Q Financial Statement

#000159552723000019 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NYC American Strategic Investment Co. Stock $nyc

2023 Q2 Form 10-Q Financial Statement

#000159552723000019 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NYC
American Strategic Investment Co. Stock $nyc